Gogglebox’s Amy Tapper hits back at follower who branded her a 'cheat' after weight-loss with Mounjaro

Gogglebox star Amy Tapper has defended herself after a follower accused her of deceiving fans by using the weight‑loss drug Mounjaro to shed 7.5 stone, without telling her audience. Tapper, 25, revealed in June last year that she had turned to the medication after feeling there was ‘nothing else she could do’ to manage her weight and turn her health around.

The criticism followed a clip Tapper shared from a Good Morning Britain interview in which she discussed her decision to use the injections. A follower who had followed her dieting journey online wrote that they felt “cheated” by the revelation, arguing that she had posted years of posts about Muscle Food deliveries and exercise as if she had achieved her results naturally. The commenter added that while there was no problem with using the injections, Tapper should not present the story in a way that could mislead fans who had offered her moral support for a natural effort. The post also questioned the notion that someone with three stone to lose should be excluded from access to the injection, claiming that the follower had been refused the treatment themselves despite persistent effort to lose weight. “I feel cheated by this,” the message began, before further complaints about the portrayal of her journey.

In response, Tapper wrote that the entire interview makes clear she began the injections last June and “haven’t done the diet you are talking about since 2023 so there’s been no lying here.” The TV personality later explained on air that her weight‑loss journey was a long, ongoing process marked by several attempts to control her weight from a young age and that the injections were part of a broader medical approach rather than a sudden fix.

During the Good Morning Britain appearance with hosts Richard Madeley and Kate Garraway, Tapper described her struggle with weight from childhood and the steps she took to address it. She recalled that doctors visits started when she was around six or seven years old and that she had tried numerous diets, sometimes losing two to three stone only to see the weight creep back. She said the decision to pursue injections came after years of dieting and an unsatisfactory search for a sustainable solution. She emphasized that the injections helped her achieve a level of weight loss that had previously seemed unattainable and noted that her doctors advised a measured, ongoing approach rather than a short‑term fix.

Tapper explained that the injections have a broader effect than appetite suppression, describing how they can influence her overall metabolism and energy balance. “Everything, literally everything,” she said, describing the transformation she experienced as the treatment progressed. She added that while there were periods of eating less and watching portions, the changes were not simply a matter of willpower; the medication helped her body work more like a typical metabolism. She stressed that her experience should not be interpreted as a quick fix, noting that she would likely remain on the medication for the foreseeable future under medical supervision.

The public conversation around Mounjaro in the UK continues to involve clinicians and health authorities. ITV’s resident GP Dr. Amir Khan joined the discussion to outline some clinical guidelines surrounding weight‑loss injections. He noted that the formal guidance varies by case, but NICE typically suggests a maximum use period of about two years for such drugs, with the necessary holistic support that accompanies meaningful weight management. He cautioned that outcomes can differ based on genetics and individual circumstances and highlighted that the cost of the medication can be a barrier for many patients.

Tapper’s disclosure situates her within a broader, ongoing debate about weight management, medical assistance, and transparency in public figures’ health journeys. The Gogglebox alum rose to fame in 2013 alongside her family, but the family left the Channel 4 show in 2018. She has since maintained a robust presence online, sharing glimpses of her daily life, her weight‑loss journey, and her evolving relationship with food and exercise. The discussion surrounding her use of Mounjaro touches on questions of access, medical guidance, and how public figures frame their weight‑loss narratives for followers who may be seeking inspiration or validation.

As Tapper continues to navigate the balance between personal health choices and public perception, she has emphasized the importance of individualized medical advice and ongoing professional support. She said that her doctor has advised that life on the injections would be monitored and adjusted as needed, with a focus on sustainable health outcomes rather than rapid loss. The remainder of her public statements suggest a willingness to engage with fans about the realities of weight management and the realities of medical treatments that can assist in reaching healthier weights when other options have not yielded lasting success.

The evolving story underscores a wider cultural moment: as weight‑loss medications become more common, public figures face scrutiny over how and when they disclose their use, as well as how to communicate the complexities of medical treatment, lifestyle change, and personal effort in an accessible, responsible way.